This study was performed to compare the therapeutic efficacy of cefuroxime with that of cefotaxime as initial antimicrobial therapies in women with complicated nonobstructive acute pyelonephritis (APN) caused by Enterobacteriaceae infections. The clinical characteristics and outcomes of a cefuroxime-treated group (n ؍ 156) were compared with those of a cefotaxime-treated group (n ؍ 166). Of these 322 women, 90 from each group were matched by propensity scores. The defervescence rates were not significantly different in the cefuroxime and cefotaxime groups at 72 h after the start of antimicrobial therapy (81.1% versus 78.9%, P ؍ 0.709). The clinical and microbiological cure rates during the follow-up visits that were 4 to 14 days after the end of the antimicrobial therapies were not significantly different in the cefuroxime versus cefotaxime groups, which were 97.8% (87/ 89) versus 97.8% (87/89) (P > 0.999) and 89.5% (68/76) versus 90.7% (68/75) (P ؍ 0.807), respectively. The median hospital stay duration and the median times to defervescence in the cefuroxime versus cefotaxime groups were 8 days (interquartile range [IQR], 7 to 10 days) versus 9 days (IQR, 7 to 11 days), respectively, and 55 h (IQR, 37 to 70 h) versus 55 h (IQR, 35 to 69 h), respectively. Bacteremia, extended-spectrum--lactamase-producing Enterobacteriaceae, C-reactive protein levels of >15 mg/dl, and white blood cell counts of >15,000/mm 3 of blood had independent effects on the rates of early clinical failure. Our data suggest that the effects of cefuroxime are not different from those of cefotaxime when they are used as an initial antimicrobial treatments for community-onset complicated nonobstructive APN in women. C ommunity-onset complicated acute pyelonephritis (APN) includes nonobstructive complicated APN and obstructive complicated APN, with the obstructive form requiring drainage and antimicrobial treatment. Extended-spectrum cephalosporin, penicillin with a -lactamase inhibitor, an aminoglycoside, and a carbapenem are recommended as the initial antimicrobial agents for the treatment of complicated APN, which includes urosepsis, obstructive complicated APN, and health care-associated catheter-associated complicated APN (1-3).However, we hypothesized that more step-down antibiotics, such as cefuroxime, can effectively be used for the treatment of community-onset nonobstructive complicated APN, the patient population of which is more homogeneous and the uropathogens are more susceptible to cephalosporin treatment than those for the obstructive form (4, 5). The antimicrobial susceptibilities of uropathogens in community-onset nonobstructive complicated APN may be more similar to those in uncomplicated APN rather than those in health care-associated or catheter-associated urinary tract infections (UTIs).In the classification of UTIs and APNs, community-onset diabetic or elderly women with APN are usually included in the complicated APN subtype and may be treated initially with antimicrobial agents, which are recommended for compli...